Add Company
Join Now

TopRx Revenue and Competitors

License our Company Data API

Bartlett, TN USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • TopRx's estimated annual revenue is currently $47.8M per year.(i)
  • TopRx's estimated revenue per employee is $201,000

Employee Data

  • TopRx has 238 Employees.(i)
  • TopRx grew their employee count by 6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$145.5M5170%$28.5MN/A
#2
$102.7M5117%N/AN/A
#3
$58.7M2921%N/AN/A
#4
$8.2M41-2%N/AN/A
#5
$29.9M14925%N/AN/A
#6
$22.5M11212%$23.6MN/A
#7
$5.6M284%N/AN/A
#8
$11.3M568%N/AN/A
#9
$13.1M657%N/AN/A
#10
$7.6M3815%N/AN/A
Add Company

Since 1987, TopRx has had one goal: provide customized solutions and outstanding customer support within the generic pharmaceutical industry. We build strong relationships with our manufacturing partners by being honest, professional, transparent, reliable--and always focused on growth. Our products are generic, we're not. Today, TopRx is still independently owned and operates as an Authorized Distributor of Record (ADR) for more than 90 generic pharmaceutical manufacturers. We also supply select brand pharmaceuticals, OTC healthcare products, vitamins and pharmacy supplies to over 7,000 pharmacies across all 50 states.

keywords:N/A

N/A

Total Funding

238

Number of Employees

$47.8M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

TopRx's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Business Inteligence ManagerReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Chairman the BoardReveal Email/Phone
5
Director IT OperationsReveal Email/Phone
6
Software EngineerReveal Email/Phone
7
Systems AdministratorReveal Email/Phone
8
Pharmaceutical SalesReveal Email/Phone
9
Account ManagerReveal Email/Phone
10
Information Technology ManagerReveal Email/Phone
Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$47.7M2418%N/A
#2
$138.6M3386%N/A
#3
$7.5M34338%N/A
#4
$170.4M5056%N/A
#5
$68.4M5476%N/A